Rechercher des projets européens

33 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

A Systems medicine approach to chronic inflammatory disease (SYSCID)

Date du début: 1 janv. 2017, Date de fin: 31 mars 2022,

"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus erythematodes and rheumatoid arthritis. We have joined 15 partners from major cohorts and initiatives in Europe (e.g.IHEC, ICGC, Twins ...
Voir le projet

 16

 TERMINÉ 

GALAXY: Gut-and-liver axis in alcoholic liver fibrosis (GALAXY)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2021,

Alcohol overuse is an important societal challenge with annual healthcare costs of over €22 billion in Europe. Alcohol is the main cause of liver cirrhosis, which is the 5th and 7th most common cause of life years lost in respectively Eastern and Western Europe. Cirrhosis is considered irreversible but its precursor, liver fibrosis, is reversible when detected before disease progression. GALAXY pr ...
Voir le projet

 12

 TERMINÉ 

The European network for observing our changing planet (ERA-PLANET)

Date du début: 1 févr. 2016, Date de fin: 31 janv. 2021,

In the last decade a significant number of projects and programmes in different domains of environmental monitoring and Earth observation have generated a substantial amount of data and knowledge on different aspects related to environmental quality and sustainability. Big data generated by in-situ or satellite platforms are being collected and archived with a plethora of systems and instruments m ...
Voir le projet

 38

 TERMINÉ 

Translational Research Network in Prostate Cancer (TransPot)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC).The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatmen ...
Voir le projet

 11

 TERMINÉ 

Big data against childhood Obesity (BigO)

Date du début: 1 déc. 2016, Date de fin: 30 nov. 2020,

Childhood and adolescent obesity is a major global and European public health problem. Currently, public actions are detached from local needs, mostly including indiscriminate blanket policies and single-element strategies, limiting their efficacy and effectiveness. The need for community-targeted actions has long been obvious, but the lack of monitoring and evaluation framework and the methodolog ...
Voir le projet

 14

 TERMINÉ 
Current diagnostic options for cancer treatment monitoring rely on imaging techniques and cannot guarantee proper assessment of therapeutic response. This project aims to develop a disruptive Point of Care (PoC) device for cancer early diagnosis and treatment monitoring as a companion diagnostics tool. One of the scientific breakthroughs of this project is the development of a “cancer stem cells” ...
Voir le projet

 8

 TERMINÉ 
Cardiovascular disease (VD) is the leading cause of mortality and morbidity in Europe and worldwide. The objective of the PRETREAT consortium is to generate a joint SME/academic European preclinical platform for providing services for detection of VD and drug development. This platform will combine the use of urinary and/or blood peptidomics in humans and in preclinical animal models of VD, togeth ...
Voir le projet

 6

 TERMINÉ 

Coordinated Research Infrastructures Building Enduring Life-science services (CORBEL)

Date du début: 1 sept. 2015, Date de fin: 31 août 2019,

The social and economic challenges of ageing populations and chronic disease can only be met by translation of biomedical discoveries to new, innovative and cost effective treatments. The ESFRI Biological and Medical Research Infrastructures (BMS RI) underpin every step in this process; effectively joining scientific capabilities and shared services will transform the understanding of biological m ...
Voir le projet

 39

 TERMINÉ 
"BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical research. The ADOPT BBMRI-ERIC proposal aims at ...
Voir le projet

 22

 TERMINÉ 

Multimodal Imaging of rare Synucleinopathies (MultISyn)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,

Despite remarkable progress in the understanding of the molecular pathogenesis of neurodegenerative diseases (NDD), no causative or disease-modifying treatment is currently available. Aggregation of misfolded proteins are thought to play a crucial role in the pathogenesis, but attempts to exploit this knowledge for novel treatments have not been successful. Also, pathogenetically relevant biomarke ...
Voir le projet

 9

 TERMINÉ 
GEO-CRADLE brings together key players representing the whole (Balkans, N. Africa and M. East) region and the complete EO value chain with the overarching objective of establishing a multi-regional coordination network that will (i) support the effective integration of existing EO capacities (space/air-borne/in-situ monitoring networks, modelling and data exploitation skills, and past project expe ...
Voir le projet

 20

 TERMINÉ 
"Amyotrophic lateral sclerosis (ALS) and Spinal Muscular Atrophy (SMA) are fatal diseases characterized by selective degeneration of motor neurons without any effective treatment. Non-neuronal cells like astrocytes play a key role in the pathogenesis of ALS and SMA. Understanding the mechanisms of cell death caused by non-neuronal cells is a major research target and it has been proposed that tran ...
Voir le projet

 3

 TERMINÉ 

Micro-ring resonator-based biophotonic system for food analysis (BIOFOS)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2016,

Current methodologies for detection of food contamination based on heavy analytical tools cannot guarantee a safe and stable food supply. The reasons are the complexity, the long time-to-result (2-3 days) and the cost of these tools, which limit the number of samples that can be practically analyzed at food processing and storage sites. The need for screening tools that will be still reliable but ...
Voir le projet

 12

 TERMINÉ 

Molecular Medicine for Bladder Cancer (BCMolMed)

Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,

BCMolMed integrates complementary and multi-disciplinary expertise of two main (research-intensive SME-academia) and five associate partners with the objective to generate a state of the art training platform on application-oriented biomarker research and systems biology. Special emphasis is placed on the efficient employment of proteomics and bioinformatics techniques to clinical research, and un ...
Voir le projet

 3

 TERMINÉ 
Currently, clinical diagnosis and monitoring of bladder cancer (BC) relies on invasive, highly costly cystoscopy. Additionally, due to high recurrence rates BC treatment is associated with frequent follow-up of patients, making BC one of the most costly types of cancer in terms of management cost. Thus there is a clear clinical need for the development of new approaches for early detection of recu ...
Voir le projet

 5

 TERMINÉ 

hERG related risk assessment of botanicals (HERGSCREEN)

Date du début: 1 mars 2012, Date de fin: 29 févr. 2016,

The main goal of this project is the establishment of a network between European, South American, North American and South African educational and research entities. This attempt will be based on an innovative scientific project aiming towards the identification of hERG (human Ether-à-go-go Related Gene) channel blockers in commonly consumed botanicals and supplements. Blocking these ion channels ...
Voir le projet

 6

 TERMINÉ 
In allergic asthma, an important health problem, disease is driven by allergen-specific Th2 immune responses. Differentiation of Th2 cells depends on their early interactions with antigen presenting cells, such as dendritic cells (DCs), and cytokines are crucial for this process. Osteopontin (Opn) was originally identified as an important cytokine for Th1 immunity and autoimmunity. Our group recen ...
Voir le projet

 2

 TERMINÉ 

Modulating motor output in the mammalian spinal cord (MODULATIONSPINALCORD)

Date du début: 1 sept. 2011, Date de fin: 31 août 2015,

The executive component of movement – the task of determining which muscles to activate, how intensely, and for how long – depends on neural circuits located in the spinal cord. At the core of these circuits are local interneurons (INTs) that regulate the pattern and frequency of motor neuron (MN) firing. Spinal motor activity is shaped by a combination of amino acid mediated excitation and inhibi ...
Voir le projet

 2

 TERMINÉ 

The emergence of bioenergetic diversity in prokaryotes (EBioDiP)

Date du début: 1 mars 2013, Date de fin: 28 févr. 2015,

Prokaryotes are characterised by an amazing metabolic diversity, which allows them to persist in diverse and often extreme habitats. Some are able to use light or organic matter to harvest energy and fix carbon, while others utilise chemo- or lithotrophic modes which use theredox potential of molecules found in their particular environment to harness energy for their survival. Molecular evolution ...
Voir le projet

 2

 TERMINÉ 

The role of mRNA-processing bodies in ageing (PAGE)

Date du début: 1 sept. 2008, Date de fin: 31 août 2014,

Recently, we and others have revealed that, in the nematode Caenorhabditis elegans, reduction of protein synthesis rates in somatic cells extends lifespan. Based on this, we postulate that the molecular factors and mechanisms that control the mRNA metabolism in post-mitotic cells are critical determinants of ageing. This project will validate this hypothesis using C. elegans as main model system, ...
Voir le projet

 2

 TERMINÉ 

MicroEncapsDelivery

Date du début: 1 sept. 2012, Date de fin: 31 août 2014,

In this multidisciplinary research proposal we aim to develop a new therapeutic platform for hepatocellular carcinoma (HCC). HCC is the third leading cause of cancer death worldwide with a death rate greater than 600,000 persons annually. Currently the main curative treatments include resection, liver transplantation, or percutaneous local ablative treatment. However, all these approaches are prim ...
Voir le projet

 2

 TERMINÉ 

Development and Neuromodulation of Intrinsic Cortical Activity (INTRICA)

Date du début: 1 juil. 2010, Date de fin: 30 juin 2014,

"We propose to study intrinsic cortical network activity in-vitro. It is already known that the cerebral cortex, both in-vivo and in-vitro, produces spontaneous patterns of electrical activity independently of extrinsic inputs. These consist of network-induced prolonged depolarizations & action potentials (UP states), alternating with periods of synaptic withdrawal, membrane hyperpolarization and ...
Voir le projet

 2

 TERMINÉ 
The number of patients with chronic kidney disease (CKD) is increasing steadily due to extended life expectancy, long lasting diabetes and obesity. Early unambiguous detection of patients at risk is both a clinical and scientific challenge. Capillary electrophoresis coupled to mass spectrometry (CE-MS), developed by Mosaiques Diagnostics (MD, SME, Germany), has been shown to be an excellent tool f ...
Voir le projet

 4

 TERMINÉ 
The application of rational drug design is proven to be more efficient than the traditional way of drug discovery since it aims to understand the molecular basis of a disease. The aim of this project is to deactivate the mutated cancerous PI3Kα protein with small molecule inhibitors. It was recently established that PIK3CA, the gene encoding the catalytic p110α subunit of PI3K, is frequently mutat ...
Voir le projet

 2

 TERMINÉ 
"Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. It is characterized pathologically by the accumulation of aggregated conformations of the presynaptic protein alpha-synuclein (ASYN) in cytoplasmic inclusions termed Lewy Bodies (LBs). Furthermore, aberrant aggregated species of ASYN accumulate in various disease states, such as Multiple System Atrophy, Diffuse LB Dise ...
Voir le projet

 11

 TERMINÉ 

European Project on Mendelian Forms of Parkinson’s Disease (MEFOPA)

Date du début: 1 avr. 2010, Date de fin: 30 sept. 2013,

"The Collaborative Project on Mendelian Forms of Parkinson’s Disease (MEFOPA) will bring together the major groups in Europe with a track-record in basic and clinical research on rare Mendelian forms of Parkinson’s disease (PD) in order to identify and validate relevant disease-related molecular pathways, drug-targets and biomarkers for disease susceptibility and progression.. Over the last years ...
Voir le projet

 27

 TERMINÉ 
"The Mediterranean and Middle East, with a combined total population of more than 400 million people, are characterized by strong environmental gradients, climate extremes and diverse economic, social and cultural identities. It is expected that throughout the 21st century the region will experience substantial adverse climate changes and face major challenges in energy demand and supply, as well ...
Voir le projet

 8

 TERMINÉ 

Translating basic research findings in major human diseases (TranSMed)

Date du début: 1 janv. 2010, Date de fin: 30 juin 2013,

Improvement of human health requires translation of the basic research discoveries into practical applications for human disease, including biomarker identification, novel clinical tools, and medications. The scope of TranSMed is to support the development of a center of excellence in the EU target area of “translational research for major human diseases”, in the convergence region of Attica, Gree ...
Voir le projet

 2

 TERMINÉ 
Inactivity and nutritional aberrations result in an expanding population of individuals with compromised metabolic function including obesity and insulin resistance. From this pool of individuals an increasing percentage develops overt diabetes leading to vast personal and social burden. Natural interventions are beneficial and exercise accompanied by weight loss can reverse insulin resistance, at ...
Voir le projet

 2

 TERMINÉ 

Stem Cells and Cancer Stem Cells in Mouse Mammary Glands (MG stem)

Date du début: 25 mai 2009, Date de fin: 24 mai 2013,

It is thought that, although cancer stem cells are a small minority in the tumor cell population, they can escape the toxicity of drugs used for treatment, as they are relatively quiescent, i.e. chemotherapy can lead effectively to remission, but not frequently to a cure. An important question that cannot be answered at present and should certainly be addressed is whether a therapeutic window can ...
Voir le projet

 2

 TERMINÉ 

Novel Interleukins for immunotherapy of Asthma (NILTHERA)

Date du début: 1 janv. 2010, Date de fin: 31 déc. 2012,

"Allergies are increasing in incidence at an alarming rate. One in three Europeans suffers from an allergy and one in ten children suffers from asthma. From the E.U. perspective, the cost from allergies in terms of health care and absenteeism from work is estimated at 45 billion euros a year. Despite prioritization of allergies and asthma in recent E.U. Framework Programme activities, there are ma ...
Voir le projet

 2

 TERMINÉ 
Cellular differentiation from stem cells to fully functional mature cells is a multi step process executed by complex transcription programs. Once differentiated, cells must faithfully maintain their identity through cellular memory mechanisms. The utilisation of genetic information stored in linear DNA sequence occurs within the three dimensional context of chromatin, chromosomes and the nucleus, ...
Voir le projet

 9

 TERMINÉ 

Multicentre discovery of breast cancer biomarkers (CANOMICS)

Date du début: 1 août 2010, Date de fin: 31 juil. 2012,

"Breast cancer is the most common cause of death from cancer among European women, and over half of the worldwide breast cancer related mortalities occur in the developing world. Despite improvements in surgical techniques and chemoradiotherapy, the ability to cure patients with breast cancer remains limited and five year survival for patients with advanced disease is dismal. Expression profiling ...
Voir le projet

 4